Exact Mass: 291.0887

Exact Mass Matches: 291.0887

Found 97 metabolites which its exact mass value is equals to given mass value 291.0887, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

NSC 204421

N-1-Naphthylphthalamic acid

C18H13NO3 (291.0895)


D006133 - Growth Substances > D010937 - Plant Growth Regulators D010575 - Pesticides > D006540 - Herbicides D016573 - Agrochemicals CONFIDENCE standard compound; EAWAG_UCHEM_ID 3097

   

2,7-Anhydro-alpha-N-acetylneuraminic acid

(1R,2R,3S,5R)-2-acetamido-7-(1,2-dihydroxyethyl)-3-hydroxy-6,8-dioxabicyclo[3.2.1]octane-5-carboxylic acid

C11H17NO8 (291.0954)


   

2-Deoxy-2,3-dehydro-N-acetylneuraminic acid

3-acetamido-4-hydroxy-2-(1,2,3-trihydroxypropyl)-3,4-dihydro-2H-pyran-6-carboxylic acid

C11H17NO8 (291.0954)


D004791 - Enzyme Inhibitors

   

Sarmentosin epoxide

Sarmentosin epoxide

C11H17NO8 (291.0954)


   

prontosil

p-[(2,4-diaminophenyl)azo]benzenesulphonamide

C12H13N5O2S (291.079)


A diphenyldiazene compound having two amino substituents at the 2- and 4-positions and an aminosulphonyl substituent at the 4-position. It was the first antibacterial drug, (introduced 1935) and the first of the sulfonamide antibiotics. C254 - Anti-Infective Agent > C29739 - Sulfonamide Anti-Infective Agent

   

Crufomate

Crufomate

C12H19ClNO3P (291.0791)


C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C250 - Antihelminthic Agent CONFIDENCE standard compound; INTERNAL_ID 237; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9553; ORIGINAL_PRECURSOR_SCAN_NO 9552 CONFIDENCE standard compound; INTERNAL_ID 237; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9578; ORIGINAL_PRECURSOR_SCAN_NO 9577 CONFIDENCE standard compound; INTERNAL_ID 237; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9598; ORIGINAL_PRECURSOR_SCAN_NO 9597 CONFIDENCE standard compound; INTERNAL_ID 237; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9618; ORIGINAL_PRECURSOR_SCAN_NO 9616 CONFIDENCE standard compound; INTERNAL_ID 237; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9590; ORIGINAL_PRECURSOR_SCAN_NO 9588 CONFIDENCE standard compound; INTERNAL_ID 237; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9626; ORIGINAL_PRECURSOR_SCAN_NO 9624

   

(2R,3R,4S,5R)-2-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-carbonitrile

(2R,3R,4S,5R)-2-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-carbonitrile

C12H13N5O4 (291.0967)


COVID info from DrugBank, PDB, Protein Data Bank, clinicaltrial, clinicaltrials, clinical trial, clinical trials D000890 - Anti-Infective Agents > D000998 - Antiviral Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

Avenalumin III

2-[(1Z,3E)-4-(4-hydroxyphenyl)buta-1,3-dien-1-yl]-4H-3,1-benzoxazin-4-one

C18H13NO3 (291.0895)


Phytoalexin isolated from oat (Avena sativa) infected with rust fungus (Puccinia coronata). Avenalumin III is found in oat and cereals and cereal products. Avenalumin III is found in cereals and cereal products. Phytoalexin isolated from oat (Avena sativa) infected with rust fungus (Puccinia coronata).

   

1,N6-Ethenoadenosine

2-(hydroxymethyl)-5-{3H-imidazo[2,1-f]purin-3-yl}oxolane-3,4-diol

C12H13N5O4 (291.0967)


   

2-Deoxy-2,3-dehydro-n-acetyl-neuraminic acid

4-Hydroxy-3-[(1-hydroxyethylidene)amino]-2-(1,2,3-trihydroxypropyl)-3,4-dihydro-2H-pyran-6-carboxylate

C11H17NO8 (291.0954)


   

Carprazidil

Carbamic acid, (5-(3,6-dihydro-1(2H)-pyridinyl)-3,3a-dihydro-2-oxo-2H-(1,2,4)oxadiazolo(2,3-a)pyrimidin-7-yl)-, methyl ester

C12H13N5O4 (291.0967)


   

Cloranolol

1-(2,5-Dichlorophenoxy)-3-tertiary-butylamino-2-propanol

C13H19Cl2NO2 (291.0793)


C - Cardiovascular system > C07 - Beta blocking agents > C07A - Beta blocking agents > C07AA - Beta blocking agents, non-selective C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents

   

Ethenoadenosine

1-(6-amino-9H-purin-9-yl)-3-(hydroxymethyl)-2-oxabicyclo[3.2.0]hept-6-ene-4,5-diol

C12H13N5O4 (291.0967)


   

Benzo(1,2-b:4,3-b')dipyrrole-2-carboxylic acid, 3,6,7,8-tetrahydro-6-(aminocarbonyl)-5-hydroxy-4-methoxy-

Benzo(1,2-b:4,3-b)dipyrrole-2-carboxylic acid, 3,6,7,8-tetrahydro-6-(aminocarbonyl)-5-hydroxy-4-methoxy-

C13H13N3O5 (291.0855)


   

Prontosil

4-[2-(2,4-Diaminophenyl)diazen-1-yl]benzene-1-sulphonamide

C12H13N5O2S (291.079)


   

Bianfugecine

5,9-Dimethoxy-7H-dibenzo(de,h)quinoline-7-one

C18H13NO3 (291.0895)


   
   
   

N-Fructosyl pyroglutamate

N-Fructosyl pyroglutamate

C11H17NO8 (291.0954)


Annotation level-3

   

(+)-toluene-4-sulfonic acid-(1-methyl-2-[2]pyridyl-ethyl ester)|(+)-Toluol-4-sulfonsaeure-(1-methyl-2-[2]pyridyl-aethylester)|(-)-toluene-4-sulfonic acid-(1-methyl-2-[2]pyridyl-ethyl ester)|(-)-Toluol-4-sulfonsaeure-(1-methyl-2-[2]pyridyl-aethylester)

(+)-toluene-4-sulfonic acid-(1-methyl-2-[2]pyridyl-ethyl ester)|(+)-Toluol-4-sulfonsaeure-(1-methyl-2-[2]pyridyl-aethylester)|(-)-toluene-4-sulfonic acid-(1-methyl-2-[2]pyridyl-ethyl ester)|(-)-Toluol-4-sulfonsaeure-(1-methyl-2-[2]pyridyl-aethylester)

C15H17NO3S (291.0929)


   

4-amino-5-cyano-7-(beta-D-ribofuranosyl)-7H-pyrrolo[2,3-d]pyrimidine|4-amino-7(beta-D-ribofuranosyl)-7H-pyrrolo[2,3-d]pyrimidine-5-carbonitrile|4-amino-7-beta-D-ribofuranosyl-7H-pyrrolo[2,3-d]pyrimidine-5-carbonitrile|7-Cyano-7-deazaadenosine|NSC-63701|toyocamycin|Vengicide|[(15)N]5-toyocamycin|[2-(13)C]-toyocamycin

4-amino-5-cyano-7-(beta-D-ribofuranosyl)-7H-pyrrolo[2,3-d]pyrimidine|4-amino-7(beta-D-ribofuranosyl)-7H-pyrrolo[2,3-d]pyrimidine-5-carbonitrile|4-amino-7-beta-D-ribofuranosyl-7H-pyrrolo[2,3-d]pyrimidine-5-carbonitrile|7-Cyano-7-deazaadenosine|NSC-63701|toyocamycin|Vengicide|[(15)N]5-toyocamycin|[2-(13)C]-toyocamycin

C12H13N5O4 (291.0967)


   
   

1-((2L)-2-carboxy-5-oxo-1-pyrrolidinyl)-1-deoxy-D-fructose|1-<(2L)-2-carboxy-5-oxo-1-pyrrolidinyl>-1-deoxy-D-fructose|N-(1-deoxy-D-fructos-1-yl)-5-oxo-L-proline|N-(1-deoxy-D-fructos-1-yl)-L-pyroglutamic acid monohydrate

1-((2L)-2-carboxy-5-oxo-1-pyrrolidinyl)-1-deoxy-D-fructose|1-<(2L)-2-carboxy-5-oxo-1-pyrrolidinyl>-1-deoxy-D-fructose|N-(1-deoxy-D-fructos-1-yl)-5-oxo-L-proline|N-(1-deoxy-D-fructos-1-yl)-L-pyroglutamic acid monohydrate

C11H17NO8 (291.0954)


   

Isosalviamine E

Isosalviamine E

C18H13NO3 (291.0895)


   
   
   

N-Formyldehydroanonaine

N-Formyldehydroanonaine

C18H13NO3 (291.0895)


   

Neodysiherbaine|neodysiherbaine A

Neodysiherbaine|neodysiherbaine A

C11H17NO8 (291.0954)


   

Lysicamine

15,16-dimethoxy-10-azatetracyclo[7.7.1.0?,?.0??,??]heptadeca-1(16),2,4,6,9(17),10,12,14-octaen-8-one

C18H13NO3 (291.0895)


Lysicamine is an alkaloid antibiotic and an oxoaporphine alkaloid. It has a role as a metabolite. Lysicamine is a natural product found in Annona purpurea, Annona papilionella, and other organisms with data available. A natural product found in Annona glabra.

   

4-((Ethylanilino)methyl)benzenesulphonic acid

3-((Ethyl(phenyl)amino)methyl)benzenesulfonic acid

C15H17NO3S (291.0929)


CONFIDENCE standard compound; INTERNAL_ID 879; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 2785; ORIGINAL_PRECURSOR_SCAN_NO 2784 CONFIDENCE standard compound; INTERNAL_ID 879; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 2801; ORIGINAL_PRECURSOR_SCAN_NO 2800 CONFIDENCE standard compound; INTERNAL_ID 879; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 2761; ORIGINAL_PRECURSOR_SCAN_NO 2760 CONFIDENCE standard compound; INTERNAL_ID 879; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 2781; ORIGINAL_PRECURSOR_SCAN_NO 2780 CONFIDENCE standard compound; INTERNAL_ID 879; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 2778; ORIGINAL_PRECURSOR_SCAN_NO 2777 INTERNAL_ID 879; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; CONFIDENCE standard compound; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 2778; ORIGINAL_PRECURSOR_SCAN_NO 2777 CONFIDENCE standard compound; INTERNAL_ID 879; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5868; ORIGINAL_PRECURSOR_SCAN_NO 5866 CONFIDENCE standard compound; INTERNAL_ID 879; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5916; ORIGINAL_PRECURSOR_SCAN_NO 5914 DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; CONFIDENCE standard compound; INTERNAL_ID 879; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5907; ORIGINAL_PRECURSOR_SCAN_NO 5904 CONFIDENCE standard compound; INTERNAL_ID 879; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5907; ORIGINAL_PRECURSOR_SCAN_NO 5904 CONFIDENCE standard compound; INTERNAL_ID 879; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5930; ORIGINAL_PRECURSOR_SCAN_NO 5929 CONFIDENCE standard compound; INTERNAL_ID 879; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5941; ORIGINAL_PRECURSOR_SCAN_NO 5939 CONFIDENCE standard compound; INTERNAL_ID 879; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5936; ORIGINAL_PRECURSOR_SCAN_NO 5934

   

1,N2-Etheno-deoxyguanosine

1,N2-Etheno-deoxyguanosine

C12H13N5O4 (291.0967)


   

Toyocamycin

Toyocamycin

C12H13N5O4 (291.0967)


An N-glycosylpyrrolopyrimidine that is tubercidin in which the hydrogen at position 5 of the pyrrolopyrimidine moiety has been replaced by a cyano group. D009676 - Noxae > D000963 - Antimetabolites D000970 - Antineoplastic Agents Toyocamycin (Vengicide) is an adenosine analog produced by Streptomyces diastatochromogenes, acts as an XBP1 inhibitor. Toyocamycin blocks RNA synthesis and ribosome function, and induces apoptosis. Toyocamycin affects IRE1α-XBP1 pathway, and inhibits XBP1 mRNA cleavage with an IC50 value of 80 nM with affecting IRE1α auto-phosphorylation. Toyocamycin specifically inhibits CDK9 with an IC50 value of 79 nM[1][2][3].

   

Avenalumin III

2-[(1Z,3E)-4-(4-hydroxyphenyl)buta-1,3-dien-1-yl]-4H-3,1-benzoxazin-4-one

C18H13NO3 (291.0895)


   

(1S,4R)-METHYL 4-AMINOCYCLOPENT-2-ENECARBOXYLATE (2R,3R)-2,3-DIHYDROXYSUCCINATE

(1S,4R)-METHYL 4-AMINOCYCLOPENT-2-ENECARBOXYLATE (2R,3R)-2,3-DIHYDROXYSUCCINATE

C11H17NO8 (291.0954)


   

4-(1-Pyrrolidinylsulforylmenthyl)phenylhydrazine hydrochloride

4-(1-Pyrrolidinylsulforylmenthyl)phenylhydrazine hydrochloride

C11H18ClN3O2S (291.0808)


   

8-(ethoxycarbonyl)-6-methoxy-7-methyl-6h-[1,2,5]oxadiazolo[4,3-e]indol-3-ium-3-olate

8-(ethoxycarbonyl)-6-methoxy-7-methyl-6h-[1,2,5]oxadiazolo[4,3-e]indol-3-ium-3-olate

C13H13N3O5 (291.0855)


   

tert-butyl 4-(2-bromoethyl)piperidine-1-carboxylate

tert-butyl 4-(2-bromoethyl)piperidine-1-carboxylate

C12H22BrNO2 (291.0834)


   

sodium 2-[4-(Dimethylamino)phenylazo]benzoate

sodium 2-[4-(Dimethylamino)phenylazo]benzoate

C15H14N3NaO2 (291.0984)


   

Carprazidil

Carprazidil

C12H13N5O4 (291.0967)


C78274 - Agent Affecting Cardiovascular System > C29707 - Vasodilating Agent

   
   

ETHYL 4-FORMYL-2,5-DIMETHYL-1-(2-THIENYLMETHYL)-1H-PYRROLE-3-CARBOXYLATE

ETHYL 4-FORMYL-2,5-DIMETHYL-1-(2-THIENYLMETHYL)-1H-PYRROLE-3-CARBOXYLATE

C15H17NO3S (291.0929)


   

N-[(4-methoxyphenyl)methyl]-N-methylbenzenesulfonamide

N-[(4-methoxyphenyl)methyl]-N-methylbenzenesulfonamide

C15H17NO3S (291.0929)


   

6-FLUOROQUINOLINE-2,3-DICARBOXYLIC ACID DIETHYL ESTER

6-FLUOROQUINOLINE-2,3-DICARBOXYLIC ACID DIETHYL ESTER

C15H14FNO4 (291.0907)


   

PIPERAZINE ACETIC ACID ANILIDE DIHYDROCHLORIDE

PIPERAZINE ACETIC ACID ANILIDE DIHYDROCHLORIDE

C12H19Cl2N3O (291.0905)


   

4-Nitro-2,6-diphenylphenol

4-Nitro-2,6-diphenylphenol

C18H13NO3 (291.0895)


   

4-Quinolinecarboxylic acid, 2-(2,3-dihydro-5-benzofuranyl)

4-Quinolinecarboxylic acid, 2-(2,3-dihydro-5-benzofuranyl)

C18H13NO3 (291.0895)


   

ETHYL 2-AMINO-5-(4-METHOXY-PHENYL)-4-METHYL-THIOPHENE-3-CARBOXYLATE

ETHYL 2-AMINO-5-(4-METHOXY-PHENYL)-4-METHYL-THIOPHENE-3-CARBOXYLATE

C15H17NO3S (291.0929)


   

Radafaxine hydrochloride

Radafaxine (hydrochloride)

C13H19Cl2NO2 (291.0793)


C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent

   

N-[2-(Piperazin-1-yl)phenyl]methylsulphonamide hydrochloride

N-[2-(Piperazin-1-yl)phenyl]methylsulphonamide hydrochloride

C11H18ClN3O2S (291.0808)


   

tert-butyl 3-(2-bromoethyl)piperidine-1-carboxylate

tert-butyl 3-(2-bromoethyl)piperidine-1-carboxylate

C12H22BrNO2 (291.0834)


   

3-THIOPHENECARBOXYLIC ACID, 2-AMINO-4-(4-METHOXYPHENYL)-5-METHYL-, ETHYL ESTER

3-THIOPHENECARBOXYLIC ACID, 2-AMINO-4-(4-METHOXYPHENYL)-5-METHYL-, ETHYL ESTER

C15H17NO3S (291.0929)


   

3-(4-benzylpyridin-1-ium-1-yl)propane-1-sulfonate

3-(4-benzylpyridin-1-ium-1-yl)propane-1-sulfonate

C15H17NO3S (291.0929)


   

Pomalidomide Impurity 4

Pomalidomide Impurity 4

C13H13N3O5 (291.0855)


   

Febuxostat Descyano Impurity

Febuxostat Descyano Impurity

C15H17NO3S (291.0929)


   

sodium 4-(4-dimethylaminophenyl)diazenylbenzoate

sodium 4-(4-dimethylaminophenyl)diazenylbenzoate

C15H14N3NaO2 (291.0984)


   

ethyl (S)-10-fluoro-3-methyl-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylate

ethyl (S)-10-fluoro-3-methyl-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylate

C15H14FNO4 (291.0907)


   

2-Propenoic acid, 2-cyano-3-[(3-Methoxy-4-nitrophenyl)aMino]-, ethyl ester

2-Propenoic acid, 2-cyano-3-[(3-Methoxy-4-nitrophenyl)aMino]-, ethyl ester

C13H13N3O5 (291.0855)


   

(S,S)-Hydroxy Bupropion

(S,S)-Hydroxy Bupropion

C13H19Cl2NO2 (291.0793)


   

2-[4-(trifluoromethyl)phenyl]-2,3-dihydro-1H-quinolin-4-one

2-[4-(trifluoromethyl)phenyl]-2,3-dihydro-1H-quinolin-4-one

C16H12F3NO (291.0871)


   

ART-CHEM-BB B014651

ART-CHEM-BB B014651

C15H17NO3S (291.0929)


   

4-allyl-5-(6-methyl-4,5,6,7-tetrahydro-1-benzothien-3-yl)-4H-1,2,4-triazole-3-thiol

4-allyl-5-(6-methyl-4,5,6,7-tetrahydro-1-benzothien-3-yl)-4H-1,2,4-triazole-3-thiol

C14H17N3S2 (291.0864)


   

Cloranolol

Cloranolol

C13H19Cl2NO2 (291.0793)


C - Cardiovascular system > C07 - Beta blocking agents > C07A - Beta blocking agents > C07AA - Beta blocking agents, non-selective C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents

   

1,N6-Ethenoadenosine

2-(hydroxymethyl)-5-{3H-imidazo[2,1-f]purin-3-yl}oxolane-3,4-diol

C12H13N5O4 (291.0967)


   

N-acetyl-2,7-anhydro-alpha-neuraminic acid

N-acetyl-2,7-anhydro-alpha-neuraminic acid

C11H17NO8 (291.0954)


   

Toyokamycin

Toyokamycin

C12H13N5O4 (291.0967)


D009676 - Noxae > D000963 - Antimetabolites D000970 - Antineoplastic Agents

   

2-[amino-[[(3S)-3-azaniumyl-3-carboxylatopropoxy]amino]methylidene]azaniumylbutanedioate

2-[amino-[[(3S)-3-azaniumyl-3-carboxylatopropoxy]amino]methylidene]azaniumylbutanedioate

C9H15N4O7- (291.0941)


   

1-(6-aminopurin-9-yl)-3-(hydroxymethyl)-2-oxabicyclo[3.2.0]hept-6-ene-4,5-diol

1-(6-aminopurin-9-yl)-3-(hydroxymethyl)-2-oxabicyclo[3.2.0]hept-6-ene-4,5-diol

C12H13N5O4 (291.0967)


   

(2r,3ar,6r,7r,7ar)-2-[(2s)-2-Amino-2-Carboxyethyl]-6,7-Dihydroxyhexahydro-2h-Furo[3,2-B]pyran-2-Carboxylic Acid

(2r,3ar,6r,7r,7ar)-2-[(2s)-2-Amino-2-Carboxyethyl]-6,7-Dihydroxyhexahydro-2h-Furo[3,2-B]pyran-2-Carboxylic Acid

C11H17NO8 (291.0954)


   

peniphenone D(1-)

peniphenone D(1-)

C15H15O6- (291.0869)


   

2-(2-methoxyphenyl)-1-methyl-3,5-dinitro-2H-pyridine

2-(2-methoxyphenyl)-1-methyl-3,5-dinitro-2H-pyridine

C13H13N3O5 (291.0855)


   

4-[2-(4-Fluorophenyl)-5-tetrazolyl]quinoline

4-[2-(4-Fluorophenyl)-5-tetrazolyl]quinoline

C16H10FN5 (291.092)


   

2-[2-(4-Tert-butylphenyl)-4-hydroxy-1,3-thiazol-5-yl]acetic acid

2-[2-(4-Tert-butylphenyl)-4-hydroxy-1,3-thiazol-5-yl]acetic acid

C15H17NO3S (291.0929)


   

4H-3,1-Benzoxazin-4-one, 2-(4-(4-hydroxyphenyl)-1,3-butadienyl)-

4H-3,1-Benzoxazin-4-one, 2-(4-(4-hydroxyphenyl)-1,3-butadienyl)-

C18H13NO3 (291.0895)


   
   

(E)-3-Benzoylmethylene-1-phenyl-2,5-pyrrolidinedione

(E)-3-Benzoylmethylene-1-phenyl-2,5-pyrrolidinedione

C18H13NO3 (291.0895)


   

1-Methyl-4-(1-methoxycarbonyl-2-pyrrolomethylene)-3-methoxycarbonyl-2-pyrazolin-5-one

1-Methyl-4-(1-methoxycarbonyl-2-pyrrolomethylene)-3-methoxycarbonyl-2-pyrazolin-5-one

C13H13N3O5 (291.0855)


   

5-Methyl-2,3-dimethoxycarbonyl-5,6-dihydropyrrolo(1,2-D)(1,2,4)triazocin-6-one

5-Methyl-2,3-dimethoxycarbonyl-5,6-dihydropyrrolo(1,2-D)(1,2,4)triazocin-6-one

C13H13N3O5 (291.0855)


   

N-acetyl-2,3-didehydro-2-deoxyneuraminic acid

N-acetyl-2,3-didehydro-2-deoxyneuraminic acid

C11H17NO8 (291.0954)


D004791 - Enzyme Inhibitors

   

(1R,2R,3S,5R)-2-acetamido-7-(1,2-dihydroxyethyl)-3-hydroxy-6,8-dioxabicyclo[3.2.1]octane-5-carboxylic acid

(1R,2R,3S,5R)-2-acetamido-7-(1,2-dihydroxyethyl)-3-hydroxy-6,8-dioxabicyclo[3.2.1]octane-5-carboxylic acid

C11H17NO8 (291.0954)


   

GS-441524

GS-441524

C12H13N5O4 (291.0967)


A C-nucleoside analog that is (2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-carbonitrile substituted by a 4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl group at position 2. It is the active metabolite of remdesivir and exhibits a broad range of inhibitory activity against various RNA viruses including HCV, parainfluenza and SARS-CoV.

   

neodysiherbaine A

neodysiherbaine A

C11H17NO8 (291.0954)


A furopyran that is (3aR,7aR)-hexahydro-2H-furo[3,2-b]pyran substituted by carboxy, (2S)-2-amino-2-carboxyethyl, hydroxy and hydroxy groups at positions 2, 2, 6, and 7, respectively (the 2R,3aR,6R,7R,7aR-stereoisomer). A convulsant isolated from the marine sponge Dysidea herbacea.

   

Deoxy-dehydro-N-acetylneuraminic acid

Deoxy-dehydro-N-acetylneuraminic acid

C11H17NO8 (291.0954)


   

THS-044

THS-044

C11H12F3N3O3 (291.0831)


THS-044 binding stabilizes the HIF2α PAS-B folded state, for regulating HIF2 activity in endogenous and clinical settings. Target: HIF2α Limited trypsin proteolysis reveals that both apo and THS-044-bound protein are efficiently cut at R330 in the extended HI loop. In the THS-044 bound state, there appears no additional proteolysis at the remaining candidate trypsin sites. In contrast, these THS-044-protected sites are protease accessible in the unliganded protein, leading its complete degradation. In parallel, NMR-based deuterium exchange measurements revealed a dramatic stabilization of the THS-044-bound protein β-sheet, with some sites experiencing 100-fold enhanced protection factors relative to the ligand-free protein. THS-044 binding stabilizes the HIF2α PAS-B folded state, for regulating HIF2 activity in endogenous and clinical settings. Target: HIF2α Limited trypsin proteolysis reveals that both apo and THS-044-bound protein are efficiently cut at R330 in the extended HI loop. In the THS-044 bound state, there appears no additional proteolysis at the remaining candidate trypsin sites. In contrast, these THS-044-protected sites are protease accessible in the unliganded protein, leading its complete degradation. In parallel, NMR-based deuterium exchange measurements revealed a dramatic stabilization of the THS-044-bound protein β-sheet, with some sites experiencing 100-fold enhanced protection factors relative to the ligand-free protein.

   

(2r,3ar,6r,7r,7ar)-2-[(2s)-2-amino-2-carboxyethyl]-6,7-dihydroxy-hexahydrofuro[3,2-b]pyran-2-carboxylic acid

(2r,3ar,6r,7r,7ar)-2-[(2s)-2-amino-2-carboxyethyl]-6,7-dihydroxy-hexahydrofuro[3,2-b]pyran-2-carboxylic acid

C11H17NO8 (291.0954)


   

1-{5-hydroxy-8-methylphenanthro[3,4-d][1,3]oxazol-4-yl}ethanone

1-{5-hydroxy-8-methylphenanthro[3,4-d][1,3]oxazol-4-yl}ethanone

C18H13NO3 (291.0895)


   

3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,12,14(19),15,17-heptaene-11-carbaldehyde

3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,12,14(19),15,17-heptaene-11-carbaldehyde

C18H13NO3 (291.0895)


   

5,11-dimethoxy-16-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2,4,6,9,11,13,15-octaen-8-one

5,11-dimethoxy-16-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2,4,6,9,11,13,15-octaen-8-one

C18H13NO3 (291.0895)


   

(2s,3r)-3-(hydroxymethyl)-3-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxirane-2-carbonitrile

(2s,3r)-3-(hydroxymethyl)-3-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxirane-2-carbonitrile

C11H17NO8 (291.0954)


   

2-[(naphthalen-1-yl)-c-hydroxycarbonimidoyl]benzoic acid

2-[(naphthalen-1-yl)-c-hydroxycarbonimidoyl]benzoic acid

C18H13NO3 (291.0895)


   

(2s,3s)-2-(hydroxymethyl)-3-({[(2s,3s,4r,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxirane-2-carbonitrile

(2s,3s)-2-(hydroxymethyl)-3-({[(2s,3s,4r,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxirane-2-carbonitrile

C11H17NO8 (291.0954)


   

2-(hydroxymethyl)-3-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxirane-2-carbonitrile

2-(hydroxymethyl)-3-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxirane-2-carbonitrile

C11H17NO8 (291.0954)


   

15,16-dimethoxy-10-azatetracyclo[7.7.1.0²,⁸.0¹³,¹⁷]heptadeca-1(16),2,4,7,9(17),10,12,14-octaen-6-one

15,16-dimethoxy-10-azatetracyclo[7.7.1.0²,⁸.0¹³,¹⁷]heptadeca-1(16),2,4,7,9(17),10,12,14-octaen-6-one

C18H13NO3 (291.0895)


   

4-amino-7-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrrolo[2,3-d]pyrimidine-5-carbonitrile

4-amino-7-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrrolo[2,3-d]pyrimidine-5-carbonitrile

C12H13N5O4 (291.0967)


   

15,16-dimethoxy-10-azatetracyclo[7.7.1.0²,⁸.0¹³,¹⁷]heptadeca-1(16),2(8),3,6,9(17),10,12,14-octaen-5-one

15,16-dimethoxy-10-azatetracyclo[7.7.1.0²,⁸.0¹³,¹⁷]heptadeca-1(16),2(8),3,6,9(17),10,12,14-octaen-5-one

C18H13NO3 (291.0895)


   

2-[(1-hydroxyethylidene)amino]-3-(4-nitro-1h-indol-3-yl)propanoic acid

2-[(1-hydroxyethylidene)amino]-3-(4-nitro-1h-indol-3-yl)propanoic acid

C13H13N3O5 (291.0855)


   

1-{5-hydroxy-8-methylphenanthro[4,3-d][1,3]oxazol-4-yl}ethanone

1-{5-hydroxy-8-methylphenanthro[4,3-d][1,3]oxazol-4-yl}ethanone

C18H13NO3 (291.0895)